mRNA instability in the nucleus due to a novel open reading frame element is a major determinant of the narrow tissue specificity of folate receptor α

Molecular and Cellular Biology

Volumn 23, Issue 6, 2003, Pages 2202-2212

  Zheng, Xuan ^a   Kelley, Karen ^a   Elnakat, Hala ^a   Yan, Wu ^a,b   Dorn, Ted ^a,c   Ratnam, Manohar ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b YALE CANCER CENTER   (United States)

^c McNeil Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FOLATE RECEPTOR ALPHA; FOLATE RECEPTOR BETA; LUCIFERASE; MESSENGER RNA; RECEPTOR; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; CELL CYCLE; CELL NUCLEUS; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; INTRON; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; RECEPTOR SENSITIVITY; REPORTER GENE; RNA STABILITY; ROUS SARCOMA ONCOVIRUS; STEADY STATE;

5' UNTRANSLATED REGIONS; AVIAN SARCOMA VIRUSES; CARRIER PROTEINS; CELL CYCLE; CELL NUCLEUS; CHORIOCARCINOMA; DNA, COMPLEMENTARY; FEMALE; FOLIC ACID; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GENES, SYNTHETIC; HELA CELLS; HUMANS; LUCIFERASES; NEOPLASM PROTEINS; NUCLEIC ACID CONFORMATION; OPEN READING FRAMES; ORGAN SPECIFICITY; RECEPTORS, CELL SURFACE; RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

ONCOVIRINAE; RICE STRIPE VIRUS; ROUS SARCOMA VIRUS;

EID: 0037372204     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.6.2202-2212.2003     Document Type: Article

References (41)

1. Akahane, K., and D. H. Pluznik. 1992. Interleukin-4 inhibits interleukin-1 alpha-induced granulocyte-macrophage colony-stimulating factor gene expression in a murine B-lymphocyte cell line via downregulation of RNA precursor. Blood 79:3188-3195.
2. Alberts, B., D. Bray, J. Lewis, M. Raff, K. Roberto, and J. D. Watson. 1989. Molecular biology of the cell, 2nd ed., chapter 9. Garland Publishing, Inc., New York, N.Y.
3. Belgrader, P., J. Cheng, X. Zhou, L. S. Stephenson, and L. E. Maquat. 1994. Mammalian nonsense codons can be cis effectors of nuclear mRNA half-life. Mol. Cell. Biol. 14:8219-8228.
4. Burkard, K. T. D., and J. S. Butler. 2000. A nuclear 3′-5′ exonuclease involved in mRNA degradation interacts with poly(A) polymerase and the hnRNA protein Np13p. Mol. Cell. Biol. 20:604-616.
5. Campbell, I. G., T. A. Jones, W. D. Foulkes, and J. Trowsdale. 1991. Folate-binding protein is marker for ovarian cancer. Cancer Res. 51:5329-5338.
6. Elwood, P. C., K. Nachmanoff, Y. Saikawa, S. T. Page, P. Pacheco, S. Roberts, and K. N. Chung. 1997. The divergent 5′ termini of the alpha human folate receptor mRNAs originate from two tissue-specific promoters and alternative splicing: characterization of the alpha hFR gene structure. Biochemistry 36:1467-1478.
7. Garber, M., S. Panchanathan, R. S. Fan, and D. L. Johnson. 1991. The phorbol ester, 12-O-tetradecanoylphorbol-13-acetate, induces specific transcription by RNA polymerase III in Drosophila Schneider cells. J. Biol. Chem. 266:20598-20601.
8. Goren, D., A. T. Horowitz, D. Tzemach, M. Tarshish, S. Zalipsky, and A. Gabizon. 2000. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin. Cancer Res. 6:1949-1957.
9. Ikeda, E., M. G. Achen, G. Breier, and W. Risau. 1995. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270:19761-19766.
10. a. Jackman, A. L., D. S. Theti, A. S. Lornaime, and V. B. Bavetsias. 2000. Exploitation of the α-isoform of folate receptor (α-FR) for the selective delivery of antifolate thymidylate synthase (TS) inhibitors. In Proceedings of the 91st Annual Meeting of the American Association for Cancer Research. American Association for Cancer Research, Philadelphia, Pa.
11. Konstantinova, I. M., V. A. Kulichkva, I. N. Evteeva, A. G. Mittenberg, I. V. Volko, J. B. Ermolaeva, and L. N. Gruse. 1999. The specific endoribonuclease activity of small nuclear and cytoplasmic alpha-RNPs. FEBS Lett. 462:407-410.
12. Lacey, S. W., J. M. Sanders, K. G. Rothberg, R. G. W. Anderson, and B. A. Kamen. 1989. Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. J. Clin. Investig. 84:715-720.
13. Leamon, C. P., and P. S. Low. 2001. Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov. Today 6:36-43.
14. Lee, C. H., P. Leeds, and J. Ross. 1998. Purification and characterization of a polysome-associated endoribonuclease that degrades c-myc mRNA in vitro. J. Biol. Chem. 273:25261-25271.
15. Leys, E. J., G. F. Crouse, and R. E. Kellems. 1984. Dihydrofolate reductase gene expression in cultured mouse cells is regulated by transcript stabilization in the nucleus. J. Cell Biol. 99:180-187.
16. Luiten, R. M., S. O. Warnaar, and D. Sanborn. 1997. Chimeric bispecific OC/TR monoclonal antibody mediates lysis of tumor cells expressing the folate-binding protein (Mov 18) and displays decreased immunogenicity in patients. J. Immunother. 20:496-504.
17. Martinez, J., Y. G. Ren, A. C. Thuressou, U. Hellman, J. Astrom, and A. Virtanen. 2000. A 54-kDA fragment of the poly (A)-specific ribonuclease is an oligomeric, processive and cap-interacting poly(A)-specific 3′ exonuclease. J. Biol. Chem. 275:24222-24230.
18. Melani, C., M. Figini, and D. Nicosia. 1998. Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody. Cancer. Res. 58:4146-4154.
19. Meskini, R. E., F. Boudouresque, and L. Ouafik. 1997. Estrogen regulation of peptidylglycine α-amidating monooxygenase messenger ribonucleic acid levels by a nuclear posttranscriptional event. Endocrinology 138:5256-5265.
20. Nakashima-Matsushita, N., T. Homma, S. Yu, T. Matsuda, N. Sunahara, T. Nakamura, M. Tsukano, M. Ratnam, and T. Matsuyama. 1999. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum. 42:1609-1616.
21. Narayan, P., and H. C. Towle. 1985. Stabilization of a specific nuclear mRNA precursor by thyroid hormone. Mol. Cell. Biol. 5:2642-2646.
22. Peoples, G. E., B. W. Anderson, T. V. Lee, J. L. Murray, A. P. Kudelka, J. T. Wharton, and G. G. Ioannides. 1999. Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers. Clin. Cancer Res. 5:4214-4223.
23. Prendergast, G. C., and M. D. Cole. 1989. Posttranscriptional regulation of cellular gene expression by the c-myc oncogene. Mol. Cell. Biol. 9:124-134.
24. Ratnam, M., H. Marquardt, J. L. Duhring, and J. H. Freisheim. 1989. Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA. Biochemistry 28:8249-8254.
25. Roberts, S. J., K. N. Chung, K. Nachmanoff, and P. C. Elwood. 1997. Tissue-specific promoters of the alpha human folate receptor gene yield transcripts with divergent 5′ leader sequences and different translational efficiencies. Biochem. J. 326:439-447.
26. Rodolfo, M., C. Melani, and C. Zilocchi. 1998. IgG2a induced by interleukin (IL) 12-producing tumor cell vaccines but not IgG1 induced by IL-4 vaccine is associated with the eradication of experimental metastases. Cancer Res. 58:5812-5817.
27. Ross, J. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59:423-450.
28. Ross, J. F., P. K. Chauduri, and M. Ratnam. 1994. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines: physiologic and clinical implications. Cancer 73:2432-2443.
29. Ross, J. F., H. Wang, F. G. Behm, P. Mathew, M. Wu, R. Booth, and M. Ratnam. 1999. Folate receptor type beta is a neutrophilic linear marker and is differentially expressed in myeloid leukemia. Cancer 85:348-357.
30. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
31. Sudimack, J., and R. J. Lee. 2000. Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev. 41:147-162.
32. Tobler, A., C. W. Miller, K. R. Johnson, M. E. Selsted, G. Rovera, and H. P. Koeffier. 1988. Regulation of gene expression of myeloperoxidase during myeloid differentiation. J. Cell. Physiol. 136:215-225.
33. Toffoli, G., C. Cernigo, A. Russo, A. Galls, M. Bagnoli, and M. Boiocchi. 1997. Overexpression of folate binding protein in ovarian cancers. Int. J. Cancer 74:193-198.
34. Vaessen, R. T. M., A. Houweling, and A. J. Van der Eb. 1987. Post-transcriptional control of class I MHC mRNA expression in adenovirus 12-transformed cells. Science 235:1486-1488.
35. 1-acid glycoprotein: evidence for hormone-regulated RNA processing. Proc. Natl. Acad. Sci. USA 81:4241-4245.
36. Wang, H., X. Zheng, F. G. Behm, and M. Ratnam. 2000. Differentiation-independent retinoid induction of folate receptor type β, a potential tumor target in myeloid leukemia. Blood 96:3529-3536.
37. Ward, C. M. 2000. Folate-targeted non-viral DNA vectors for cancer gene therapy. Curr. Opin. Mol. Ther. 2:182-187.
38. Weitman, S. D., R. H. Lark, L. R. Coney, D. W. Fort, V. Frasca, V. R. Zurawski, and B. A. Kamen. 1992. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52:3396-3401.
39. Weitman, S. D., A. G. Weinberg, L. R. Coney, V. R. Zurawski, and D. Jennings. 1992. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res. 52:6708-6711.
40. Wu, M., W. Gunning, and M. Ratnam. 1999. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. Cancer Epidemiol. Biomarkers Prev. 8:775-782.
41. Yan, W., and M. Ratnam. 1995. Preferred sites of glycosylphosphatidylinositol modification in folate receptors and constraints in the primary structure of the hydrophobic portion of the signal. Biochemistry 3:14594-14600.